Medac

From WikiMD's WELLNESSPEDIA

Medac is a global pharmaceutical company that specializes in the diagnosis and treatment of diseases in the areas of oncology, urology, autoimmune diseases, and other specialty care. The company is headquartered in Wedel, Germany, and has subsidiaries and representatives in more than 90 countries worldwide.

History[edit]

Medac was founded in 1970 by Volker Altenhof, a pharmacist, and his wife, Ingrid Altenhof, a medical doctor. The company initially focused on the development and production of diagnostic and therapeutic agents for rare diseases. Over the years, Medac has expanded its product portfolio to include a wide range of pharmaceuticals and medical products.

Products[edit]

Medac's product portfolio includes pharmaceuticals for the treatment of cancer, autoimmune diseases, urological diseases, and other specialty care areas. The company also offers diagnostic agents and medical devices. Some of the company's key products include Methotrexate, a chemotherapy drug used to treat certain types of cancer, and Tepadina, a conditioning agent used in stem cell transplantation.

Research and Development[edit]

Medac's research and development activities are focused on the discovery and development of innovative therapies for the treatment of diseases with high unmet medical need. The company's R&D efforts are guided by a deep understanding of disease biology and the application of advanced scientific and technological capabilities.

Corporate Responsibility[edit]

Medac is committed to operating in a socially and environmentally responsible manner. The company's corporate responsibility initiatives include efforts to reduce its environmental footprint, promote ethical business practices, and contribute to the communities in which it operates.

See Also[edit]

References[edit]


This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.